secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0001683168-23-003090
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals files updated investor presentation; no material new information disclosed
--------------------------------------------------------------------------------

- Filed Form 8-K with Item 7.01 disclosure attaching an updated investor presentation dated May 10, 2023.
- Presentation covers Sonoma's stabilized hypochlorous acid (HOCl) products for dermatology, wound care, and other applications.
- Company sells products directly or via partners in 55 countries; no specific financial results or guidance provided.
- No changes in leadership, M&A, debt, litigation, or regulatory actions reported.
- Forward-looking statements include risks typical of the business; no new material facts for investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823003090/0001683168-23-003090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823003090/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-003090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer